Aryl sulfone compounds of formula (I) and (II) are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders.
申请公布号
CA2561525(A1)
申请公布日期
2005.11.24
申请号
CA20052561525
申请日期
2005.04.14
申请人
AMGEN, INC.
发明人
FAN, PINGCHEN;SUN, DAQING;LABELLE, MARC;YAN, XUELEI;REW, YOSUP;KAKUTANI, MAKOTO;HE, XIAO;GOTO, HIROYUKI;POWERS, JAY P.;MCMINN, DUSTIN L.
